Scientific Communications Consulting, Bhirangi

Active

Address

c/o Latika Bhirangi, Avenue Général Guisan 58 B, 1009 Pully

Legal Form

Sole proprietorship (SP)

UID / VAT

CHE-242.458.297 MWST

Commercial Register Number

CH-550-1153585-6

Seat

Pully

c/o Latika Bhirangi, Avenue Général Guisan 58 B, 1009 Pully

Purpose

Écritures et conseils relatifs aux maladies, aux médicaments et à leur vente, ainsi que prestations dans les domaines de la communication et de la formation des docteurs sur les nouveaux médicaments, leur vente et sur les nouvelles maladies.

Management

AI-generated content
Discover company networks and board member connections

Join Our Beta Program

We are actively developing the platform. Sign up for beta access to get exclusive early access to new features.

Publications

09/09/2016

0, 0
Scientific Communications Consulting Bhirangi à Le Mont-sur-Lausanne CHE-242 458 297 (FOSC du 21 07 2014 p 0/1623969) Siège transféré à Pully Nouvelle adresse avenue Général Guisan 58 B c/o Latika Bhirangi 1009 Pully Bhirangi Latika est maintenant à Pully

Frequently Asked Questions

What is the legal status of Scientific Communications Consulting, Bhirangi?

Scientific Communications Consulting, Bhirangi is Active in the Swiss Commercial Register.

What is the UID (VAT) number of Scientific Communications Consulting, Bhirangi?

The UID (VAT) number of Scientific Communications Consulting, Bhirangi is CHE-242.458.297.

Where is Scientific Communications Consulting, Bhirangi located?

Scientific Communications Consulting, Bhirangi is located in Pully with its registered address at c/o Latika Bhirangi, Avenue Général Guisan 58 B, 1009 Pully.

What is the legal form of Scientific Communications Consulting, Bhirangi?

Scientific Communications Consulting, Bhirangi is registered as a Sole proprietorship (SP) in Switzerland.

What is the purpose of Scientific Communications Consulting, Bhirangi?

Écritures et conseils relatifs aux maladies, aux médicaments et à leur vente, ainsi que prestations dans les domaines de la communication et de la formation des docteurs sur les nouveaux médicaments, leur vente et sur les nouvelles maladies.